Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

[11] Kassouf E(2005)Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC Lung Cancer (Amsterdam, Netherlands) 48 129-783

[12] Rassy EE(2017)Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial Ann Oncol 28 777-962

[13] Kourie HR(2016)PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer J Clin Oncol 34 953-4198

[14] Martin J(2002)Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431 J Clin Oncol 20 4191-1649

[15] Campeau MP(2001)Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors Ann Oncol 12 1643-1639

[16] Auperin A(2003)Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer Ann Oncol 14 1634-1381

[17] Le Pechoux C(2001)A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients Ann Oncol 12 1375-2666

[18] Pignon JP(2015)Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04 J Clin Oncol 33 2660-199

[19] Koning C(2015)Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 16 187-1002

[20] Jeremic B(2008)Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial J Thorac Oncol 3 994-1966

[11] Kassouf E(2005)Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC Lung Cancer (Amsterdam, Netherlands) 48 129-783

[12] Rassy EE(2017)Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial Ann Oncol 28 777-962

[13] Kourie HR(2016)PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer J Clin Oncol 34 953-4198

[14] Martin J(2002)Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431 J Clin Oncol 20 4191-1649

[15] Campeau MP(2001)Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors Ann Oncol 12 1643-1639

[16] Auperin A(2003)Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer Ann Oncol 14 1634-1381

[17] Le Pechoux C(2001)A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients Ann Oncol 12 1375-2666

[18] Pignon JP(2015)Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04 J Clin Oncol 33 2660-199

[19] Koning C(2015)Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 16 187-1002

[20] Jeremic B(2008)Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial J Thorac Oncol 3 994-1966